Map3k3I441M knock-in model demonstrates lesion formation in adults requires PI3K activation, suggesting mTOR inhibition may offer therapeutic benefits across age groups.
The Map3k3I441M knock-in mouse model reveals an age-dependent mechanism in cerebral cavernous malformation (CCM) pathogenesis, wherein PI3K pathway activation is required for lesion formation in adults but not juveniles. Notably, rapamycin treatment effectively inhibited lesions across age groups, underscoring mammalian target of rapamycin (mTOR) inhibition as a potential therapy. This commentary highlights mechanistic insights from the Map3k3I441M knock-in mouse model, emphasizing the age-dependent role of PI3K signaling in CCM formation. It discusses the potential synergy between MAP3K3 and PIK3CA mutations, explores the therapeutic potential of mTOR inhibition, and considers the potential influence of pre-conceptional environmental exposures on CCM susceptibility.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: